Candida guilliermondii fungemia in patients with hematologic malignancies - Wikidata - wikimedia - TriplyDB

Candida guilliermondii fungemia in patients with hematologic malignancies

Candida guilliermondii fungemia in patients with hematologic malignancies

http://www.wikidata.org/entity/Q34719843

about

Disruption of Protein Mannosylation Affects Candida guilliermondii Cell Wall, Immune Sensing, and Virulence Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance.Intravenous Catheter-Associated Candidemia due to Candida membranaefaciens: The First Iranian Case Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options.Increasing Non-Albicans Candida in Hematological Patients with Fluconazole Prophylaxis: A Case Series.The Genomes of Four Meyerozymacaribbica Isolates and Novel Insights into the Meyerozymaguilliermondii Species Complex.Fungemia in a university hospital: an epidemiological approach.Drug-resistant cassettes for the efficient transformation of Candida guilliermondii wild-type strains.A TRP5/5-fluoroanthranilic acid counter-selection system for gene disruption in Candida guilliermondii.Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan.

P2860

Q28818151-1EBC215B-0B1A-4FA5-9C3A-C2485C7365D3 Q30445376-5B8B7DE7-A68A-469E-ABAE-B3A278057257 Q35719482-50CF5C75-05BA-4C22-A855-605473AD35C7 Q35768705-576C0404-0099-4A42-9D16-FFC40DF252DA Q37132105-912A0923-5C08-470C-86C9-5A142F691FBC Q37480190-6A1E646B-9E64-47D3-8A65-4235CAA821BB Q37805648-52644B12-88FC-4BFF-B4A3-45F783E1F170 Q38883793-0C18846E-6F6E-4B2B-BD3A-958CB4613299 Q39420285-52EEC50D-930B-45A4-8A4F-60C399E8FE42 Q40239343-FFC0A715-7B80-4193-B2C8-762078B563B8 Q40446419-1F723E64-442D-4C4D-B83B-B2CA1DE8DF44 Q40942390-90960370-9138-4E95-A0C6-CAE143EFDE8A Q41833155-63E981EC-44DA-4645-9174-90F1411AFFC0 Q42119440-9A137E5E-2BD6-429A-90E8-53F2DC4171E6 Q50092926-7D96DDFC-17D1-4DAE-B102-92505A89AF39 Q50134029-B31990CA-8C0E-4EE1-841F-C8631D245BB3 Q50976863-296FC83D-05A2-45A6-B519-7BCDDD47F751 Q52610012-FD177C28-AE7B-4878-951A-13A08F42429E Q52625634-F0276A52-ED2E-448D-90D2-4320265F87F6 Q55292648-47B1B0D9-44D6-40E7-86C0-F1EB8DFB2F78

P2860

Candida guilliermondii fungemia in patients with hematologic malignancies

http://www.wikidata.org/entity/Q34719843

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Candida guilliermondii fungemia in patients with hematologic malignancies

@ast

Candida guilliermondii fungemia in patients with hematologic malignancies

@en

Candida guilliermondii fungemia in patients with hematologic malignancies

@nl

type

label

Candida guilliermondii fungemia in patients with hematologic malignancies

@ast

Candida guilliermondii fungemia in patients with hematologic malignancies

@en

Candida guilliermondii fungemia in patients with hematologic malignancies

@nl

prefLabel

Candida guilliermondii fungemia in patients with hematologic malignancies

@ast

Candida guilliermondii fungemia in patients with hematologic malignancies

@en

Candida guilliermondii fungemia in patients with hematologic malignancies

@nl

P1433

Q34719843-BC122109-AAEE-41ED-9145-9C679D496DA5

P1476

Q34719843-E9C26E72-406F-4EC0-87C2-82F2FB32DD0B

P2093

Q34719843-2F33CDC5-32C4-467A-AE4C-49B4F4B2CA2B

Q34719843-3C2BC166-4BCA-4300-94C0-4F069280B91A

Q34719843-A08FC5DE-4960-4469-AC96-4154D36751B7

Q34719843-AC2C0297-6629-47F5-A244-D77107CDFBEC

Q34719843-CC1C392E-057C-442F-87FD-301C346EAB73

Q34719843-E4253506-A3EF-4F1A-AE77-1B1A704BFEB8

Q34719843-E6D904DC-9DC0-48B8-85BA-8C0428288B97

P2860

Q34719843-00AEE488-E5F8-4A3F-88EA-6821A9B7F9DF

Q34719843-05591645-8029-4662-8C4A-5B2548DA1A5C

Q34719843-08924ADF-077A-4BFA-831C-D267F99DED8A

Q34719843-0A8D8B69-291F-4F06-B202-C48D8529F9AB

Q34719843-0DB1AC21-DEC9-4551-B8CB-43D5D139D714

Q34719843-1353BCCB-01C8-46E0-9684-30BCBE72F880

Q34719843-1ABC9F82-9B85-4D31-B800-322984156164

Q34719843-1FB924AC-4021-4952-82AC-D7021710A63A

Q34719843-28BA03B4-1072-4128-A390-A8B6842CB85D

Q34719843-2CC9BF45-4639-4C8D-9AE4-B75CB3D5C706

P304

Q34719843-C5D6C920-C64B-4F6C-9C0F-CBF652EE16FC

P31

Q34719843-82E2E4E1-D151-4989-8E21-B2A4A1A5B993

P356

Q34719843-0E633284-E6D3-4631-9EE4-955B37B8E23E

P407

Q34719843-ACF9FCD1-C8E5-4A07-8217-D7A0E1AE24F9

P433

Q34719843-6528109F-61E1-494B-A6F7-90843CE0EE97

P478

Q34719843-35469D09-F04E-47E3-9F22-22F8486F42AF

P577

Q34719843-88AA18FA-CF8C-4903-965A-56DCCD5B828B

P5875

Q34719843-DB4C7AAD-FAFC-4204-8F4C-8416836900B8

P698

Q34719843-0DE33865-657D-4313-8F3B-77E14E3B621F

P932

Q34719843-B1F54DE2-CCA8-4FA1-89E5-173A759D13B9

P356

P1433

Journal of Clinical Microbiology

P1476

Candida guilliermondii fungemia in patients with hematologic malignancies

@en

P2093

Corrado Girmenia

http://www.w3.org/2001/XMLSchema#string

Elisabetta Spreghini

http://www.w3.org/2001/XMLSchema#string

Francesco Barchiesi

http://www.w3.org/2001/XMLSchema#string

Francesco Cristini

http://www.w3.org/2001/XMLSchema#string

Giampaolo Pizzarelli

http://www.w3.org/2001/XMLSchema#string

Giorgio Scalise

http://www.w3.org/2001/XMLSchema#string

Pietro Martino

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Par

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.

Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.

Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort

Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.

Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

P304

2458-2464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00356-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6960503

http://www.w3.org/2001/XMLSchema#string

P698

16825364

http://www.w3.org/2001/XMLSchema#string

P932

1489483

http://www.w3.org/2001/XMLSchema#string